Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation

Leukemia ◽  
2017 ◽  
Vol 31 (4) ◽  
pp. 1020-1022 ◽  
Author(s):  
S Kobayashi ◽  
A Kobayashi ◽  
Y Osawa ◽  
S Nagao ◽  
K Takano ◽  
...  
Keyword(s):  
Stem Cell ◽  
Hematopoietic Stem Cell Transplantation ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Hematopoietic Stem Cell ◽  
Donor Cell ◽  
Cell Leukemia ◽  
Hematopoietic Stem ◽  
Donor Cell Leukemia

scholarly journals Pediatric donor cell leukemia after allogeneic hematopoietic stem cell transplantation in AML patient from related donor

2015 ◽  
Vol 8 (1) ◽  
pp. 5 ◽  
Author(s):  
Lucina Bobadilla-Morales ◽  
Helia J Pimentel-Gutiérrez ◽  
Sergio Gallegos-Castorena ◽  
Jenny A Paniagua-Padilla ◽  
Citlalli Ortega-de-la-Torre ◽  
...  
Keyword(s):  
Stem Cell ◽  
Hematopoietic Stem Cell Transplantation ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Hematopoietic Stem Cell ◽  
Donor Cell ◽  
Cell Leukemia ◽  
Hematopoietic Stem ◽  
Related Donor ◽  
Donor Cell Leukemia

scholarly journals A 54-Year-Old Woman with Donor Cell Origin of Multiple Myeloma after Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of CML

2016 ◽  
Vol 2016 ◽  
pp. 1-3 ◽  
Author(s):  
Erika Maestas ◽  
Shikha Jain ◽  
Patrick Stiff
Keyword(s):  
Multiple Myeloma ◽  
Stem Cell ◽  
Hematopoietic Stem Cell Transplantation ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Hematopoietic Stem Cell ◽  
Myeloid Leukemia ◽  
Donor Cell ◽  
Secondary Malignancy ◽  
Hematopoietic Stem

Chronic myeloid leukemia is a myeloproliferative disorder that may be treated with hematopoietic stem cell transplantation (HSCT). While posttransplantation relapse of disease resulting from a failure to eradicate the patient’s original leukemia could occur, patients may also rarely develop a secondary malignancy or myelodysplastic syndrome (MDS) of donor origin termed donor cell leukemia (DCL). Cases of donor-derived acute myeloid leukemia (AML) or MDS after HSCT or solid tumor transplantation have been published. However, very few cases of donor-derived multiple myeloma (MM) exist. We describe a patient who developed a donor-derived MM following allogeneic HSCT from a sibling donor.

Sign in / Sign up

Export Citation Format

Share Document